Multiple Myeloma (MM) MRD kits

Multiple Myeloma (MM) MRD kits

Panel of standardized antibodies for immunophenotypic detection of minimal residual disease (MM-MRD) in multiple myelomas by flow cytometry

Advantages of standardizing flow cytometry for the detection of multiple myelomas
  • Achieve comparable laboratory results
  • Avoiding ineffective treatments
  • Have better treatment follow-up

MM MRD Kit

The MM-MRD kit contains a panel of standardized antibodies following the recommendations of the EuroFlow consortium for immunophenotypic detection of minimal residual disease (MM-MRD) in multiple myelomas by multiparametric high-definition flow cytometry.

 


Pacific Blue * FITC PE PerCP-Cyanine 5.5 PE-Cyanine 7 APC APC-750
Tube 1 CD138 CD27 CD38 CD56 CD45 CD19 CD117 CD81
Tube 2 CD138 CD27 CD38 CD56 CD45 CD19 cyIgKappa cyIgLambda
*CD27 is not included in the kit. It is recommended to add this antibody during the labeling process.
Example
Comparison of the expression intensity of normal (blue) or pathological (red) plasma cells for the antigens detected by the MM-MRD kit.
The APS (Automatic Population Separator) based on the Principal Component Analysis (PCA) shows a multiparametric representation of normal (blue) or pathological (red) plasma cells during diagnosis.

Product
Format
Size
Product code
MM MRD Tube 1
Lyophilized
20 tests
CYT-MM-MRD-T1
MM MRD
Lyophilized
20 tests
CYT-MM-MRD